Growth Hormone Activity in Polycystic Ovary Syndrome

描述（由申请人提供）：此职业发展补助金将准备候选人追求她的目标，成为一个独立资助的院士致力于调查多囊卵巢综合征（PCOS）的病理生理学。PCOS综合征影响5-8%的育龄妇女，导致不孕症以及糖尿病和心脏病风险增加。该提案的长期目标是提高对PCOS病理生理学的理解，以便开发更有效的治疗方法。在这项申请中提出的新研究受益于一个强大的，多学科的高级研究人员团队的指导，并使用一种新的生长激素拮抗剂作为生理探针。生长激素拮抗剂提供了第一个机会，以隔离生长激素在这种复杂和了解甚少的疾病的影响。该建议的短期目标是确定生长激素和IGF-1对PCOS过度胰岛素抵抗和高雄激素血症的贡献。这项建议将首先在不太复杂的瘦型PCOS患者中研究这些影响，然后在更常见和更严重的肥胖型PCOS患者中研究这些影响。这一建议的总体假设是，生长激素阻滞剂将1）降低PCOS瘦女性的胰岛素抵抗程度大于正常女性; 2）PCOS瘦女性雄激素的降低程度大于对照女性。与瘦型PCOS女性相比，这些影响预计在肥胖PCOS女性中会被放大。在所有组中，生长激素活性将首先在次最大水平下被阻断以保持正常的IGF-1水平，然后在高水平下诱导IGF-1缺乏，以区分生长激素和IGF-1在PCOS中的作用。除了指导研究外，候选人还将接受肥胖研究技术和生物统计学方面的高级培训，这将使她能够巩固她在临床研究方面的基础。该应用程序受益于内分泌学和生殖内分泌学部门以及通用临床研究中心提供的强大的研究密集型环境和资源。受保护的时间进行指导研究和教学培训的结合是理想的，将使她能够发展经验，技能和初步数据，以发展成为一名独立的临床医生-科学家。

DESCRIPTION (provided by applicant): This career development grant will prepare the candidate to pursue her goal of becoming an independently funded academician devoted to investigating the pathophysiology of Polycystic Ovary Syndrome (PCOS). The poorly understood syndrome of PCOS affects 5-8% of reproductive age women and results in infertility as well as an increased risk of diabetes and heart disease. The long term objective of this proposal is to improve understanding of the pathophysiology of PCOS in order that more effective treatments can be developed. The novel research proposed in this application benefits from mentoring by a strong, multidisciplinary team of senior investigators and uses a new growth hormone antagonist as a physiological probe. The growth hormone antagonist offers the first opportunity to isolate the effects of growth hormone in this complex and poorly understood disease. The short term goal of this proposal is to determine the contribution of growth hormone and IGF-1 to the excess insulin resistance and hyperandrogenism in PCOS. This proposal will investigate these effects first in the less complex lean PCOS patients and then in the more common and more severe obese PCOS patients. The overall hypotheses of this proposal are that growth hormone blockade will 1) decrease insulin resistance in lean women with PCOSto a greater extent than in normals; and 2) decrease androgens in lean women with PCOS more than in control women. These effects are expected to be magnified in obese women with PCOS in comparison to lean women with PCOS. In all groups growth hormone activity will first be blocked at a submaximal level to preserve normal IGF-1 levels, and then at a high level to induce IGF-1 deficiency in order to distinguish between the roles of growth hormone and IGF-1 in PCOS. In addition to the mentored research, the candidate will undertake advanced training in obesity research techniques and biostatistics that will allow her to solidify her foundation in clinical research. This application benefits from the robust, research-intensive environment and resources provided by the Divisions of Endocrinology and Reproductive Endocrinology and the General Clinical Research Center at UNC. The combination of protected time for mentored research and didactic training are ideal and will allow her to develop the experience, skills and preliminary data to develop as an independent clinician- scientist.